Expression of LMW tropomyosin in Type 2 diabetes. by Stuart A. Savill (3129060)

Expression of HMW tropomyosin in Type 2 diabetes. by Stuart A. Savill (3129060)

TRIT1 exhibits substrate-specific restriction against cy-tRNA^TrpCCA in <i>S</i>. <i>pombe</i>. by Abdul Khalique (5029442)

Subjects:

TPM1 protein expression in response to inflammatory cytokines. by Stuart A. Savill (3129060)

TRIT1 MTS-dependent modification of mt-tRNAs in <i>S</i>. <i>pombe</i>. by Abdul Khalique (5029442)

Subjects:

Position 32 as a determinant of differential IPTase activity for cy-tRNA^TrpCCA in eukaryotes. by Abdul Khalique (5029442)

Subjects:

Determinants of TRIT1 critical for cy-tRNA^SerUCA-mediated TMS in <i>S</i>. <i>pombe</i>. by Abdul Khalique (5029442)

Subjects:

Decreased remyelination initiation is observed in Scribble cKO mice following focal demyelination in corpus callosum. by Andrew A. Jarjour (343100)

“…In the contralateral (unlesioned) hemisphere (CL), no difference was seen in the proportion of axons in the corpus callosum that were myelinated in Scribble cKO compared to wild-type animals (A–C). Fewer remyelinated axons were observed in corpus callosum in the lesion area in Scribble cKO mice (E) relative to controls (D) as quantified in F; 0.4–0.5 μm: WT = 80.0% ± 9.8%, cKO = 41.3% ± 8.9% myelinated; 0.5–0.6 μm: WT = 79.4% ± 6.3%, cKO = 41.5% ± 9.5% myelinated; 0.6–0.7 μm: WT = 91.6% ± 3.0%, cKO = 44.3% ± 8.7% myelinated; >0.7 μm: WT = 92.7% ± 1.9%, cKO = 47.9% ± 2.5% myelinated. …”

Inhibition of F/P tyrosine kinase by imatinib in CEL patients decreased phosphorylation of JAK2, Stat3 and Stat5 in a time-dependent manner. by Bin Li (39349)

IL-7 decreases apoptosis of HIV-1-infected CD4⁺ T cells. by Andrea Introini (284643)

Intranasal administration of telmisartan decreases amyloid plaques and CD11b staining in the cortex and hippocampus of 4-month old 5XFAD mice. by Nofar Torika (3169497)

Ethanol intoxication combined with burn injury decreases miRNA155 expression in T cells. by Xiaoling Li (129705)

Tim-3 deficiency enhances the levels of proinflammatory cytokines and decreases the parasite burden. by Houbao Qi (11996039)

Vectorized siRNA TMPRSS2-ERG IV-SQ impaired tumour growth and restored differentiation <i>in vivo</i>. by Giorgia Urbinati (554921)

“…Using the Kruskal & Wallis followed by Tukey and/or Dunnet test, a statistical decrease (*** = <i>p</i><0.001) of tumour growth was observed when mice were treated with siRNA TMPRSS2-ERG IV-SQ NPs. …”

Study Flow Diagram. by Elizabeth S. Munroe (21568166)

Subjects:

HCMV US27 correlates with decreased expression of p21 and Sestrin-2. by Carolyn C. Tu (663652)

Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. by Elizabeth S. Munroe (21568166)

Subjects:

Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

Subjects:

Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

Subjects: